WO2013160349A2 - Composition cosmétique comprenant un oligosaccharide phosphorylé et un polysaccharide - Google Patents

Composition cosmétique comprenant un oligosaccharide phosphorylé et un polysaccharide Download PDF

Info

Publication number
WO2013160349A2
WO2013160349A2 PCT/EP2013/058493 EP2013058493W WO2013160349A2 WO 2013160349 A2 WO2013160349 A2 WO 2013160349A2 EP 2013058493 W EP2013058493 W EP 2013058493W WO 2013160349 A2 WO2013160349 A2 WO 2013160349A2
Authority
WO
WIPO (PCT)
Prior art keywords
composition
phosphorylated
oligosaccharides
weight
phosphorylated oligosaccharides
Prior art date
Application number
PCT/EP2013/058493
Other languages
English (en)
Other versions
WO2013160349A3 (fr
Inventor
Céline DERRIPS
Cécile Fiandino
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Publication of WO2013160349A2 publication Critical patent/WO2013160349A2/fr
Publication of WO2013160349A3 publication Critical patent/WO2013160349A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Definitions

  • Cosmetic composition comprising a phosphorylated oligosaccharide and a polysaccharide
  • the present invention relates to compositions, in particular cosmetic and/or dermatological compositions, comprising a phosphorylated oligosaccharide and a particular polysaccharide, and also to the use of these compositions in a process for treating human keratin materials.
  • compositions of the invention are intended for caring for and/or making up keratin materials.
  • the term "keratin materials” is intended to denote, for example, the skin, mucous membranes, the lips, the scalp, the eyelashes, the eyebrows and the hair.
  • Oligosaccharides of low molecular weight which have properties as regards lightening the complexion, for exfoliating the skin (WO 2003/013448) or for promoting the cell proliferation of keratinocytes or fibroblasts and for inhibiting the synthesis of certain proteases of elastase type are known (Andres E. et al., Pathol. Biol. (Paris), 2006 Sep; 54(7):420-5; WO 2002/020622).
  • Phosphooligosaccharides such as Pos-Ca would also make it possible to improve the elasticity of skin tissue and to combat the signs of aging of the skin (JP2009/227632).
  • phosphorylated oligosaccharides may be reflected by an appreciable decrease in the viscosity and/or destabilization of the composition.
  • phosphorylated oligosaccharides must be fully dissolved and/or dispersed in the composition.
  • a composition which is too fluid is difficult to apply to keratin materials. Such a composition runs on keratin materials, in particular on the skin, to which it is applied. Its application to the keratin materials that it is desired to treat lacks precision and therefore makes it relatively unattractive to use.
  • compositions comprising a phosphorylated oligosaccharide and having good stability over time, especially after storage for 2 months at room temperature (25°C) or at higher temperature, without substantial fluidization and/or destabilization.
  • the object of the present invention is, precisely, to satisfy these needs.
  • the present invention relates to a composition
  • a composition comprising, in a physiologically acceptable medium containing an aqueous medium, i) at least one phosphorylated oligosaccharide and ii) at least one saccharide polymer as described below other than the phosphorylated oligosaccharide(s) i).
  • composition according to the invention is in particular a cosmetic and/or pharmaceutical composition, in particular a dermatological composition.
  • a phosphorylated oligosaccharide to a composition comprising a particular saccharide polymer does not significantly affect the viscosity of said composition and thus enables it to be formulated in a form that is suited to its handling during its application. Moreover, this makes it possible to add the phosphorylated oligosaccharide during the various preparation phases without modifying the viscosity.
  • compositions comprising a polysaccharide according to the invention and a phosphorylated oligosaccharide are stable and homogeneous.
  • this specific combination of phosphorylated oligosaccharide- saccharide polymer also makes it possible to confer, on a composition of the invention, a pleasant appearance and, during the application thereof, comfortable feel properties.
  • the present invention relates to a nontherapeutic treatment process for caring for or making up keratin materials, comprising the application to said keratin materials of a composition in accordance with the invention.
  • phosphorylated oligosaccharide means a linear or branched polysaccharide compound consisting of or containing:
  • the 2 to 10 monosaccharide units may in particular be pentoses or hexoses.
  • the monosaccharide units are hexoses, and may be selected, independently of each other, from the group consisting of:
  • aldohexoses namely fructose, psicose, sorbose and tagatose
  • ketohexoses namely glucose, galactose, mannose, allose, altrose, gulose, idose and talose
  • deoxymonosaccharides namely rhamnose, fucose fubulose, pneumose and quinovose.
  • the monosaccharide units may all be glucoses.
  • phosphorylated oligosaccharides denotes, without preference, several molecules of the same phosphorylated oligosaccharide or a mixture of several phosphorylated oligosaccharides.
  • the phosphorylated oligosaccharides may be in the form of a complex with cations, in particular calcium.
  • the phosphorylated oligosaccharides may more specifically be phosphorylated maltooligosaccharides, i.e. phosphorylated oligosaccharides consisting of 2 (maltose), 3 (maltotriose), 4 (maltotetraose), 5 (maltopentaose), 6 (maltohexaose), 7 (maltoheptaose), 8 (maltooctaose), 9 (maltononaose) or 10 (maltodecaose) glucose units linked together via a-1 -4 glycoside bonds.
  • phosphorylated maltooligosaccharides i.e. phosphorylated oligosaccharides consisting of 2 (maltose), 3 (maltotriose), 4 (maltotetraose), 5 (maltopentaose), 6 (maltohexaose), 7 (maltoheptaose), 8 (maltooctao
  • the phosphorylated oligosaccharides may comprise or consist of a mixture of maltotriose phosphate, maltotetraose phosphate and maltopentaose phosphate.
  • the phosphorylated maltooligosaccharides preferably bear 1 or 2 phosphate groups and are optionally combined with calcium.
  • the phosphorylated oligosaccharides may in particular be those sold by the company Ezaki Glico, such as calcium phosphooligosaccharides POs-Ca (INCI name: Calcium Phosphoryl Oligosaccharides) which are a mixture of maltooligosaccharides to which are attached at least 1 or 2 phosphorus groups and calcium ions.
  • Ezaki Glico such as calcium phosphooligosaccharides POs-Ca (INCI name: Calcium Phosphoryl Oligosaccharides) which are a mixture of maltooligosaccharides to which are attached at least 1 or 2 phosphorus groups and calcium ions.
  • POs phosphooligosaccharides
  • EC 3.2.1 .1 bacterial liquefying a-amylase
  • glucoamylase EC 3.2.1 .3
  • pullulanase EC 3.2.1 .41
  • PO-1 a major fraction known as PO-1 , which is a mixture consisting of monophosphorylated maltotriose, maltotetraose and maltopentaose
  • PO-2 a minor fraction known as PO-2, which is a mixture consisting in major amount of phosphorylated maltopentaose and maltohexaose, and in minor amount of phosphorylated maltotriose, maltotetraose, maltoheptaose and maltooctaose, the phosphorylated maltooligosaccharides each having at least two phosphate groups (Kamasaka et al., Biosci. Biotech. Biochem., 1995, 59(8), 1412- 1416).
  • fraction PO-1 consists of six monophosphorylated compounds (Kamasaka et al., Biosci. Biotech. Biochem., 1997, 61 (2), 238-244):
  • 3-phosphoryl oligosaccharides [3 3 -phosphoryl maltotetraose (maltotetraose bearing a phosphate group on the carbon at C3 of the third glucosyl residue) and 3 4 -phosphoryl maltopentaose (maltopentaose bearing a phosphate group on the carbon at C3 of the fourth glucosyl residue)]; and
  • the two fractions PO-1 and PO-2 may form a complex with calcium ions (calcium phosphooligosaccharides or POs-Ca).
  • This complex contains about 5% calcium, by weight of calcium relative to the total weight of the POs-Ca.
  • the POs may be obtained by hydrolysis of potato starch, according to the process described by Kamasaka et al., Biosci. Biotech. Biochem., 1995, 59(8), 1412-1416. According to this process, 1 g of potato starch is suspended in 100 ml of a solution containing 6 mM NaCI, 2 mM CaCI 2 and 3.0 U/ml of BLA (bacterial liquefying cc-amylase).
  • BLA bacterial liquefying cc-amylase
  • the solution After having gradually heated the suspension to 100°C to liquefy it, the solution is cooled and incubated at 50°C for 1 hour. 1 ml of glucoamylase at 600 U/ml, 1 ml of pullulanase at 200 U/ml and 1 ml of BLA at 300 U/ml are then added, and the reaction mixture is incubated at 40°C for 2 hours.
  • amylolytic reaction progress may be monitored by the starch-iodine complex method and/or by the glucose oxidase method (see Barham and Trinder, Analyst, 1972, 97, 142-146). Since the action of the amylolytic enzymes is blocked by the phosphate groups linked to the glucose residues, the phosphorylated oligosaccharides are present in the indigestible fraction of this enzymatic treatment.
  • the solution is heated in a boiling water bath for 10 minutes and then applied onto a column of anion-exchange resin (for example Chitopearl BCW-2501 ; 1 ⁇ x 2 cm or an equivalent column) which has been equilibrated with 20 mM acetate buffer (pH 4.5).
  • anion-exchange resin for example Chitopearl BCW-2501 ; 1 ⁇ x 2 cm or an equivalent column
  • the neutral saccharides are washed from the column with the buffer and the phosphorylated oligosaccharides are then eluted with the same 20 mM acetate buffer (pH 4.5) also containing 0.5 M NaCI.
  • the eluted phosphorylated oligosaccharides may be desalted, for example by precipitation with ethanol (at a concentration of 70% v/v) followed by washing with 70% ethanol before dissolution in deionized water, or by passing through a cation-exchange column (for example Dowex 50WX4, 20-50 mesh or an equivalent column).
  • a cation-exchange column for example Dowex 50WX4, 20-50 mesh or an equivalent column.
  • the phosphorylated oligosaccharides complexed with calcium may be prepared by neutralizing the desalted solution of phosphooligosaccharides with Ca(OH) 2 to pH 6.5. The calcium content is then 5 g of calcium per 100 g of total weight.
  • the phosphorylated oligosaccharide(s) may be present in the composition according to the invention in a content ranging from 0.01 % to 10% by weight and preferably from 0.1 % to 5% by weight relative to the total weight of the composition.
  • composition according to the invention comprises at least one saccharide polymer other than the phosphorylated oligosaccharides i) chosen from galactomannan gums and scleroglucan gums, and mixtures thereof.
  • the galactomannan gums that may be used according to the invention are more particularly modified galactomannan gums.
  • the galactomannan gums are especially guar gums and more particularly modified guar gums.
  • modified galactomannan gum means galactomannan gums alkylated with at least one C-1-8 alkyl group, galactomannan gums hydroxyalkylated with at least one Ci-s hydroxyalkyl group or galactomannan gums acylated with at least one Ci-s acyl group.
  • hydroxyalkyl guar gum in particular of C1 -C6 and more particularly hydroxypropylated, especially such as the product sold under the name Jaguar HP 105 by the company Rhodia.
  • the scleroglucans used in accordance with the invention are nonionic polysaccharides preferably corresponding to formula (I): in which the degree of polymerization n ranges from 500 to 1600.
  • sderoglucans of microbial origin are advantageously used, obtained, for example, by aerobic fermentation of a glucose medium with a fungus of the Sclerotium type and having the structure of a D-glucopyranose homopolymer.
  • scleroglucan gums that may be used in the present invention are, in a nonlimiting manner, the products sold under the name Actigum CS, in particular Actigum CS 1 1 , by the company Sanofi Bio Industries and under the names Amigum and Amigel by the company Alban Muller International.
  • the saccharide polymer described previously may be present in the composition according to the invention in a content ranging from 0.05% to 10% by weight, preferably ranging from 0.1 % to 5% by weight and preferentially ranging from 0.5% to 3% by weight, relative to the total weight of the composition.
  • the phosphorylated oligosaccharide(s) and the saccharide polymer described previously may be present in the composition according to the invention in a compound (i)/saccharide polymer according to the invention weight ratio ranging from 0.1 to 10 and preferably ranging from 0.5 to 5.
  • the viscosity of a composition of the invention may be measured via any method known to those skilled in the art, and especially according to the following conventional method. Thus, the measurement may be carried out at 25°C using a Contraves TV or Rheomat 180 viscometer equipped with a spindle rotating at 200 rpm. Those skilled in the art may select the spindle for measuring the viscosity from the spindles M1 , M2, M3 and M4 on the basis of their general knowledge, so as to be able to perform the measurement.
  • composition according to the invention comprises a physiologically acceptable aqueous medium.
  • physiologically acceptable medium is intended to denote a medium that is compatible with human keratin materials and/or fibers, for instance, in a nonlimiting manner, the skin, mucous membranes, the nails, the scalp and/or the hair.
  • This physiologically acceptable aqueous medium comprises an aqueous phase, optionally as a mixture, or not, with one or more organic solvents, such as a Ci-Cs alcohol, in particular ethanol, isopropanol, tert-butanol, n-butanol, polyols such as glycerol, propylene glycol, butylene glycol, and polyol ethers.
  • organic solvents such as a Ci-Cs alcohol, in particular ethanol, isopropanol, tert-butanol, n-butanol, polyols such as glycerol, propylene glycol, butylene glycol, and polyol ethers.
  • a composition according to the invention may also comprise a fatty phase, which may comprise oils, gums and waxes normally used in the field of application under consideration.
  • a composition according to the invention may also comprise at least one fatty phase chosen from a fatty phase which is solid at room temperature (20-25°C) and atmospheric pressure and/or a fatty phase which is liquid at room temperature (20-25°C) and atmospheric pressure.
  • a liquid fatty phase suitable for implementing the invention may comprise a volatile oil, a nonvolatile oil, and a mixture thereof.
  • a volatile or nonvolatile oil may be a hydrocarbon-based oil, in particular of animal or plant origin, a synthetic oil, a silicone oil, a fluoro oil or a mixture thereof.
  • a solid fatty phase suitable for implementing the invention may be chosen, for example, from pasty fatty substances and gums, and mixtures thereof.
  • oils or waxes that may be used in the invention, mention may be made of mineral oils (liquid petroleum jelly), plant oils (liquid fraction of shea butter, sunflower oil), animal oils (perhydrosqualene), synthetic oils (purcellin oil), silicone oils or waxes (cyclomethicone) and fluoro oils (perfluoropolyethers), beeswax, carnauba wax or paraffin wax. Fatty alcohols and fatty acids (stearic acid) may be added to these oils.
  • the proportion of the fatty phase may range from 5% to 80% by weight and preferably from 5% to 50% by weight relative to the total weight of the composition.
  • the oils, waxes, emulsifiers and co- emulsifiers used in the composition in emulsion form are chosen from those conventionally used in the cosmetics field.
  • An emulsifier and a coemulsifier may be present in a composition of the invention in a proportion ranging from 0.3% to 30% by weight and in particular from 0.5% to 20% by weight relative to the total weight of the composition.
  • An emulsion according to the invention may also contain lipid vesicles.
  • a composition according to the invention is an oily solution or gel
  • the fatty phase may represent more than 90% of the total weight of the composition.
  • a composition according to the invention may also contain adjuvants that are common in the field under consideration, such as surfactants, emulsifiers, hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic additives, preserving agents, antioxidants, solvents, fragrances, fillers, UVA and/or UVB screening agents (organic or mineral, soluble or insoluble), pigments, fibers, chelating agents, odor absorbers, dyestuffs and other cosmetic or pharmaceutical active agents.
  • adjuvants that are common in the field under consideration, such as surfactants, emulsifiers, hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic additives, preserving agents, antioxidants, solvents, fragrances, fillers, UVA and/or UVB screening agents (organic or mineral, soluble or insoluble), pigments, fibers, chelating agents, odor absorbers, dyestuffs and other cosmetic or pharmaceutical active agents.
  • these various adjuvants are those conventionally used in the cosmetics field, and may range, for example, from 0.01 % to 30% of the total weight of the composition. In general, the amounts are adjusted as a function of the formulation prepared. Depending on their nature, these adjuvants may be introduced into the fatty phase, into the aqueous phase and/or into lipid spherules.
  • hydrophilic gelling agents that may be used in the invention, mention may be made of carboxyvinyl polymers (carbomer), acrylic copolymers such as acrylate/alkylacrylate copolymers, polyacrylamides, natural gums and clays, and, as lipophilic gelling agents, mention may be made of modified clays such as bentones, metal salts of fatty acids, for instance aluminum stearates, and hydrophobic silica.
  • composition of the invention may be provided in any galenical form that may be envisioned.
  • a composition according to the invention may have the form of an aqueous or aqueous/alcoholic solution; a dispersion; a water-in-oil, oil-in-water or multiple emulsion; a suspension; microcapsules or microparticles; vesicular dispersions of ionic and/or nonionic type; or an aerosol composition also comprising a pressurized propellant.
  • the composition according to the invention may be an oil-in-water emulsion.
  • a composition according to the invention may be provided in the form of a haircare composition, in particular a shampoo, a hair-setting lotion, a treating lotion, a styling cream or gel, a dye composition, in particular an oxidation dye composition, hair-restructuring lotions, a perming composition (in particular a composition for the first step of a perming), a lotion or a gel for combating hair loss, or an antiparasitic shampoo.
  • a haircare composition in particular a shampoo, a hair-setting lotion, a treating lotion, a styling cream or gel, a dye composition, in particular an oxidation dye composition, hair-restructuring lotions, a perming composition (in particular a composition for the first step of a perming), a lotion or a gel for combating hair loss, or an antiparasitic shampoo.
  • a cleansing, protecting, treating or caring composition for the face, for the hands, for the feet, for the major anatomical folds or for the body (for example, day cream, night cream, makeup-removing cream, antisun composition, protective or care body milk, after-sun milk, lotion, gel or foam for caring for the skin, such as cleansing lotions, or artificial tanning compositions); a composition for making up the body or face, such as a foundation; a bath composition; a deodorizing composition comprising, for example, a bactericidal agent; an aftershave composition; a depilatory composition; a composition for countering insect stings or bites; a pain-relieving composition; or a dermatological or pharmaceutical composition for treating certain skin diseases, such as eczema, rosacea, psoriasis, lichen or severe pruritus.
  • composition according to the invention when a composition according to the invention is intended for a use of peeling type, it can also be provided in all the formulation forms mentioned above, provided that it is easily removed by rinsing, in particular in the form of an aqueous gel or an aqueous or aqueous/alcoholic solution.
  • a composition according to the invention can be applied by any means which makes possible uniform distribution and in particular using a cotton wool swab, a rod, a brush, a gauze, a spatula or a pad, or else by spraying, and can be removed by rinsing with water or using a mild detergent.
  • a composition according to the invention can be provided in a fluid form of vaporizable or nonvaporizable liquid type, in the form of a paste, of a direct or inverse emulsion, or of an impregnated support or gel.
  • a composition according to the invention may be in a solid form, in particular a compact, pulverulent or cast solid form, or in a stick form.
  • a composition according to the invention may also be in the form of a care product, an antisun or after-sun product, a daily photoprotective care product, a body product, a foundation to be applied to the face or the neck, a concealer product, a complexion corrector, a tinted cream or a makeup base for making up the face, or a body makeup composition.
  • a composition according to the invention may be used for the purposes of improving the general condition of the epidermis, in particular of the skin, and especially for maintaining or restoring its physiological functions and/or its esthetic appearance.
  • composition according to the invention can advantageously be employed in order to combat aging of the epidermis, to maintain and/or stimulate the moisturizing and/or to combat the drying out of the skin, to improve the tonicity of the skin, to maintain or restore the suppleness and elasticity of the skin, to improve the mineralization of the epidermis, to improve the vitality of the epidermis, to facilitate intercellular exchanges, and to combat chapping and the cracked appearance of the skin.
  • a composition according to the invention may be intended for a cosmetic and/or dermatological application.
  • An aqueous gel was prepared with three different thickening polymers (two polysaccharide polymers according to the invention and one polymer outside the invention), and, for each of the polymers, the gel was prepared with or without the phosphorylated oligosaccharide.
  • the viscosity of the aqueous gels obtained was then measured after 24 hours of storage at room temperature (viscosity measured at 25°C using a Contraves TV viscometer with an M3 spindle after 10 minutes of rotation at 200 revolutions/minute).
  • Example 2A Example 2B (outside the (invention) invention)
  • Example 3A Example 3B (outside the (outside the invention) invention)
  • a facial care cream having the following composition was prepared:
  • glycol stearate mixture (100 EO)
  • Carboxyvinyl polymer (Carbopol 981 from
  • Composition 4 obtained is stable and has the appearance of a thick cream, which is fondant when applied to the skin.
  • composition applied to the face makes it possible to revive the radiance of the complexion.
  • An aqueous gel was prepared with two different thickening polymers (a polysaccharide polymer according to the invention and a polymer outside the invention).
  • the viscosity of the aqueous gels obtained was then measured after 24 hours of storage at room temperature (viscosity measured at 25°C using a Contraves TV viscometer with an M3 spindle after 10 minutes of rotation at 200 revolutions/minute).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition comprenant, dans un milieu aqueux physiologiquement acceptable : i) au moins un oligosaccharide phosphorylé et ii) au moins un saccharide polymère autre que les oligosaccharides phosphorylés i) choisi parmi des gommes de galactomannane et des gommes de scléroglucane, et des mélanges de ceux-ci. L'invention porte également sur l'utilisation pour le soin et le maquillage de matières kératiniques.
PCT/EP2013/058493 2012-04-26 2013-04-24 Composition cosmétique comprenant un oligosaccharide phosphorylé et un polysaccharide WO2013160349A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR1253846A FR2989892B1 (fr) 2012-04-26 2012-04-26 Composition cosmetique comprenant un oligosaccharide phosphoryle et un polysaccharide
FR1253846 2012-04-26
US201261644188P 2012-05-08 2012-05-08
US61/644,188 2012-05-08

Publications (2)

Publication Number Publication Date
WO2013160349A2 true WO2013160349A2 (fr) 2013-10-31
WO2013160349A3 WO2013160349A3 (fr) 2014-06-26

Family

ID=46598717

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/058493 WO2013160349A2 (fr) 2012-04-26 2013-04-24 Composition cosmétique comprenant un oligosaccharide phosphorylé et un polysaccharide

Country Status (2)

Country Link
FR (1) FR2989892B1 (fr)
WO (1) WO2013160349A2 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015118123A1 (fr) * 2014-02-07 2015-08-13 Novozymes A/S Compositions pour la production de sirops de glucose
WO2016087445A1 (fr) * 2014-12-01 2016-06-09 Novozymes A/S Production améliorée de sirops de glucose
US20170312208A1 (en) * 2014-11-20 2017-11-02 Ezaki Glico Co., Ltd. Hair papilla cell activator
CN109806213A (zh) * 2019-04-01 2019-05-28 贵州阿斯科科技开发有限公司 一种中药植物去屑组合物、植物洗发露及其制备方法
CN114259453A (zh) * 2022-01-20 2022-04-01 中科东方细胞科技有限公司 一种敏感肌舒缓修复喷雾及其制备方法与应用
US11690795B2 (en) 2017-12-13 2023-07-04 Roquette Freres Thickening and stabilising system of natural origin suitable, in particular, for preparing cosmetic products

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020622A1 (fr) 2000-09-11 2002-03-14 Indústria e Comércio de Cosméticos Natura Ltda. Melange d'oligosaccharides a base de fucose non-sulfate, cosmetique ou composition pharmaceutique comportant ledit melange et son utilisation dans l'industrie cosmetique ou pharmaceutique
WO2003013448A1 (fr) 2001-08-09 2003-02-20 Color Access, Inc. Procede d'exfoliation de la peau
JP2009227632A (ja) 2008-03-25 2009-10-08 Ezaki Glico Co Ltd 酵素合成グリコーゲンを含有する皮膚外用剤。

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125917C (fr) * 1961-07-10
JPS567711A (en) * 1979-07-02 1981-01-27 San Ei Chem Ind Ltd Cosmetic
GB8419737D0 (en) * 1984-08-02 1984-09-05 Beecham Group Plc Detergent compositions
JP3240102B2 (ja) * 1994-08-11 2001-12-17 江崎グリコ株式会社 リン酸化糖とその製造方法
EP1325737B1 (fr) * 2000-10-12 2009-12-16 Kao Corporation Agents reducteurs des pores de la peau et d'amelioration de l'elasticite cutanee
KR100730588B1 (ko) * 2005-09-30 2007-06-20 (주)케피로스 헤어 컨디셔닝용 화장료 조성물
CN101282708B (zh) * 2005-10-05 2013-03-20 江崎格力高株式会社 含有磷酸化糖的皮肤外用剂
JP5726533B2 (ja) * 2008-11-28 2015-06-03 江崎グリコ株式会社 リン酸化糖、ポリフェノールおよびフッ素を含む、食品および組成物
JP2012077044A (ja) * 2010-10-05 2012-04-19 Ezaki Glico Co Ltd 皮膚外用剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020622A1 (fr) 2000-09-11 2002-03-14 Indústria e Comércio de Cosméticos Natura Ltda. Melange d'oligosaccharides a base de fucose non-sulfate, cosmetique ou composition pharmaceutique comportant ledit melange et son utilisation dans l'industrie cosmetique ou pharmaceutique
WO2003013448A1 (fr) 2001-08-09 2003-02-20 Color Access, Inc. Procede d'exfoliation de la peau
JP2009227632A (ja) 2008-03-25 2009-10-08 Ezaki Glico Co Ltd 酵素合成グリコーゲンを含有する皮膚外用剤。

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANDRES E. ET AL., PATHOL. BIOL. (PARIS, vol. 54, no. 7, September 2006 (2006-09-01), pages 420 - 5
BARHAM; TRINDER, ANALYST, vol. 97, 1972, pages 142 - 146
KAMASAKA ET AL., BIOSCI. BIOTECH. BIOCHEM., vol. 59, no. 8, 1995, pages 1412 - 1416
KAMASAKA ET AL., BIOSCI. BIOTECH. BIOCHEM., vol. 61, no. 2, 1997, pages 238 - 244

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015118123A1 (fr) * 2014-02-07 2015-08-13 Novozymes A/S Compositions pour la production de sirops de glucose
CN105960176A (zh) * 2014-02-07 2016-09-21 诺维信公司 用于生产葡萄糖糖浆的组合物
US10337041B2 (en) 2014-02-07 2019-07-02 Novozymes A/S Compositions for producing glucose syrups
EP3712240A1 (fr) * 2014-02-07 2020-09-23 Novozymes A/S Compositions pour la production de sirops de glucose
US11136607B2 (en) 2014-02-07 2021-10-05 Novozymes A/S Compositions for producing glucose syrups
US11667938B2 (en) 2014-02-07 2023-06-06 Novozymes A/S Compositions for producing glucose syrups
US20170312208A1 (en) * 2014-11-20 2017-11-02 Ezaki Glico Co., Ltd. Hair papilla cell activator
US10543159B2 (en) * 2014-11-20 2020-01-28 Ezaki Glico Co., Ltd. Hair papilla cell activator
WO2016087445A1 (fr) * 2014-12-01 2016-06-09 Novozymes A/S Production améliorée de sirops de glucose
US11690795B2 (en) 2017-12-13 2023-07-04 Roquette Freres Thickening and stabilising system of natural origin suitable, in particular, for preparing cosmetic products
CN109806213A (zh) * 2019-04-01 2019-05-28 贵州阿斯科科技开发有限公司 一种中药植物去屑组合物、植物洗发露及其制备方法
CN114259453A (zh) * 2022-01-20 2022-04-01 中科东方细胞科技有限公司 一种敏感肌舒缓修复喷雾及其制备方法与应用

Also Published As

Publication number Publication date
FR2989892A1 (fr) 2013-11-01
FR2989892B1 (fr) 2014-05-16
WO2013160349A3 (fr) 2014-06-26

Similar Documents

Publication Publication Date Title
EP1600143B1 (fr) PRÉPARATION DERMIQUE À USAGE EXTERNE CONTENANT UN SUCRE DÉRIVÉ DE LA a,a-TRÉHALOSE
JP4116243B2 (ja) 皮膚用組成物
WO2013160349A2 (fr) Composition cosmétique comprenant un oligosaccharide phosphorylé et un polysaccharide
KR20090098083A (ko) 저분자 및 고분자 히알루론산과 유근피로부터 분리된다당체 추출물을 함유하는 노화방지용 조성물
JP2006232820A (ja) 毛髪セット力増強剤及び毛髪セット力増強方法並びに毛髪セット用組成物
US20050265944A1 (en) Carbohydrate-based anti-wrinkle and tissue remodelling compounds
BR112017010689B1 (pt) composição, processo cosmético e uso cosmético da composição e de éster de ácido
EP3769750A1 (fr) Composition d'acide hyaluronique pour usage externe sur la peau et son utilisation
JP3249844B2 (ja) 皮膚化粧料
KR20200060837A (ko) 천연물 복합 추출물을 유효성분으로 포함하는 주름 개선용 하이드로겔 화장료 조성물
KR102171523B1 (ko) 가늘어진 모발의 외관을 처리하는 방법
US20080260675A1 (en) Depolymerized Scleroglucan for Regulating and Improving the Moisture Content of the Skin
KR101605324B1 (ko) 각질 제거 및 수분량 증가를 통한 건조 및 가려움 완화 효과를 가지는 보습용 화장료 조성물
CN106361595A (zh) 一种智妍导入溶媒精华液
JP2006249077A (ja) リン酸化糖を含有する皮膚外用剤
Baptista et al. Bacterial polysaccharides: cosmetic applications
JP2024508944A (ja) 局所用のバイオポリマー
KR20190021114A (ko) 식물 추출물을 포함하는 피부 항염, 피지 분비 억제용, 또는 여드름 개선용 조성물
CN113304067A (zh) 保湿组合物及其制备方法和应用
JPH09241150A (ja) 皮膚外用剤
KR20170130865A (ko) 식물 추출물을 포함하는 피부 항염 또는 피부 보습용 조성물
CN115279338A (zh) 用于皮肤保湿的植物法国腊菊去分化细胞的可局部施用裂解物
FR2989894A1 (fr) Utilisation d'oligosaccharides phosphoryles pour reduire l'apparence et/ou la visibilite des pores de la peau
KR102195161B1 (ko) 모발 회복 블렌드를 포함하는 개인 관리 조성물
JP2019006693A (ja) 美容方法

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 13720844

Country of ref document: EP

Kind code of ref document: A2